Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Shaff Eric D.
Director at Seres Therapeutics. Filing since 28 Mar 2016.
CIK 0001643734
Company
Date
Role
Action
Shares
Amount
Of holding
MCRB
Seres Therapeutics, Inc.
17 Aug 2026
Director
Sold on a plan
263
$1.20K
2.1%
MCRB
Seres Therapeutics, Inc.
18 May 2026
Director
Sold on a plan
259
$1.95K
2.1%
MCRB
Seres Therapeutics, Inc.
15 Feb 2026
Director
Sold on a plan
259
$2.19K
2.2%
MCRB
Seres Therapeutics, Inc.
15 Nov 2025
Director
Sold on a plan
217
$3.75K
1.9%
MCRB
Seres Therapeutics, Inc.
18 Aug 2025
Director
Sold on a plan
217
$3.61K
2.0%
MCRB
Seres Therapeutics, Inc.
16 May 2025
CEO and President
Sold on a plan
220
$1.60K
2.1%
MCRB
Seres Therapeutics, Inc.
18 Feb 2025
CEO and President
Sold on a plan
12,726
$10.31K
6.2%
MCRB
Seres Therapeutics, Inc.
18 Nov 2024
CEO and President
Sold on a plan
2,505
$1.35K
1.4%
MCRB
Seres Therapeutics, Inc.
28 Oct 2024
CEO and President
Sold on a plan
8,748
$6.04K
5.0%
MCRB
Seres Therapeutics, Inc.
16 Aug 2024
CEO and President
Sold on a plan
2,518
$2.12K
1.7%
MCRB
Seres Therapeutics, Inc.
15 May 2024
CEO and President
Sold on a plan
2,435
$2.29K
1.7%
MCRB
Seres Therapeutics, Inc.
16 Feb 2024
CEO and President
Sold on a plan
11,549
$12.47K
7.9%
MCRB
Seres Therapeutics, Inc.
30 Oct 2023
CEO and President
Sold on a plan
8,552
$11.55K
6.9%
MCRB
Seres Therapeutics, Inc.
28 Jan 2019
See Remarks
Sold, plan not stated
4,378
$25.19K
25.4%
MCRB
Seres Therapeutics, Inc.
26 Jan 2018
See Remarks
Sold, plan not stated
2,780
$30.64K
34.8%
MCRB
Seres Therapeutics, Inc.
30 Jun 2016
CFO and EVP
Sold, plan not stated
4,533
$133.90K
100%
MCRB
Seres Therapeutics, Inc.
28 Jun 2016
CFO and EVP
Sold, plan not stated
1,667
$48.09K
100%
MCRB
Seres Therapeutics, Inc.
27 Jun 2016
CFO and EVP
Sold, plan not stated
3,334
$93.35K
100%
MCRB
Seres Therapeutics, Inc.
4 Apr 2016
CFO and EVP
Sold, plan not stated
6,568
$189.49K
100%
MCRB
Seres Therapeutics, Inc.
31 Mar 2016
CFO and EVP
Sold, plan not stated
7,663
$201.57K
100%
MCRB
Seres Therapeutics, Inc.
28 Mar 2016
CFO and EVP
Sold, plan not stated
5,473
$131.74K
100%
21 decisions on file.
